Should induction chemotherapy be considered for all patients with gastric cancer?
Authors: Hickish, T.F. and Cunningham, D.
Journal: European Journal of Surgical Oncology
Volume: 20
Issue: 2
Pages: 185-186
ISSN: 0748-7983
Abstract:An overall response rate of 70% is reported with systemic chemotherapy in gastric cancer, with 13% complete responses. Systemic chemotherapy should now be considered for all patients with gastric cancer, but its use should be prudent and in the context of clinical trials.
Source: Scopus
Preferred by: Tamas Hickish
Should induction chemotherapy be considered for all patients with gastric cancer?
Authors: Hickish, T.F. and Cunningham, D.
Journal: Eur J Surg Oncol
Volume: 20
Issue: 2
Pages: 185-186
ISSN: 0748-7983
Abstract:An overall response rate of 70% is reported with systemic chemotherapy in gastric cancer, with 13% complete responses. Systemic chemotherapy should now be considered for all patients with gastric cancer, but its use should be prudent and in the context of clinical trials.
Source: PubMed
Should induction chemotherapy be considered for all patients with gastric cancer?
Authors: Hickish, T.F. and Cunningham, D.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Volume: 20
Issue: 2
Pages: 185-186
eISSN: 1532-2157
ISSN: 0748-7983
Abstract:An overall response rate of 70% is reported with systemic chemotherapy in gastric cancer, with 13% complete responses. Systemic chemotherapy should now be considered for all patients with gastric cancer, but its use should be prudent and in the context of clinical trials.
Source: Europe PubMed Central